Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Y Amy Cheung

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 1, 2009
Structural identifiability and indistinguishability of compartmental modelsJames W T Yates, R D Owen Jones, Mike Walker, et al.
Frontiers in Pharmacology|September 22, 2022
Cost effectiveness analyses of pharmacological treatments in heart failureAudrey Huili Lim, Nusaibah Abdul Rahim, Jinxin Zhao, et al.
Frontiers in Oncology|February 13, 2024
Pediatric oncology drug development and dosage optimizationS Y Amy Cheung, Justin L Hay, Yu-Wei Lin, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
The AAPS Journal|October 14, 2025
Effective Visualizations Using "vachette" to Assess and Communicate Pharmacometric Model ResultsJos Lommerse, Anna Largajolli, James Craig, et al.
Frontiers in Pharmacology|January 31, 2025
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analysesYu-Wei Lin, Anna Largajolli, A Yin Edwards, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis PatientsThao-Nguyen Pham, Anna Largajolli, Maria Luisa Sardu, et al.
Journal of Biopharmaceutical Statistics|December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trialsBernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
British Journal of Clinical Pharmacology|December 21, 2025
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeuticsJustin L Hay, Amandine Manon, Hunter Stephens, et al.
Mathematical Biosciences|May 17, 2008
Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modellingS Y Amy Cheung, Neil D Evans, Michael J Chappell, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|April 1, 2009
Structural identifiability and indistinguishability of compartmental modelsJames W T Yates, R D Owen Jones, Mike Walker, et al.
Frontiers in Pharmacology|September 22, 2022
Cost effectiveness analyses of pharmacological treatments in heart failureAudrey Huili Lim, Nusaibah Abdul Rahim, Jinxin Zhao, et al.
Frontiers in Oncology|February 13, 2024
Pediatric oncology drug development and dosage optimizationS Y Amy Cheung, Justin L Hay, Yu-Wei Lin, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
The AAPS Journal|October 14, 2025
Effective Visualizations Using "vachette" to Assess and Communicate Pharmacometric Model ResultsJos Lommerse, Anna Largajolli, James Craig, et al.
Frontiers in Pharmacology|January 31, 2025
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analysesYu-Wei Lin, Anna Largajolli, A Yin Edwards, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis PatientsThao-Nguyen Pham, Anna Largajolli, Maria Luisa Sardu, et al.
Journal of Biopharmaceutical Statistics|December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trialsBernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
British Journal of Clinical Pharmacology|December 21, 2025
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeuticsJustin L Hay, Amandine Manon, Hunter Stephens, et al.
Mathematical Biosciences|May 17, 2008
Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modellingS Y Amy Cheung, Neil D Evans, Michael J Chappell, et al.
Pageof 5